GC Biopharma Receives MFDS Approval for World’s First Recombinant Anthrax Vaccine
Hand-out
Press Releases
April 9, 2025

GC Biopharma Receives MFDS Approval for World’s First Recombinant Anthrax Vaccine

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX,

bradford

The Bradford Era

Local & Social